8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
May 1, 2026·SEC
Material company update
Mar 26, 2026·SEC
22nd Century Group, Inc.(XXII)Earnings, Financials & Key Ratios
XXII•NASDAQ
$4.36
Price updated Jul 7, 2026
About22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.Show more
- Revenue$7M-40.7%
- EBITDA-$10M+19.2%
- Net Income-$5M+66.7%
- EPS (Diluted)-52.88+99.9%
- Gross Margin-44.5%-120.3%
- EBITDA Margin-145.54%-36.2%
- Operating Margin-161.95%-37.9%
- Net Margin-71.7%+43.8%
- ROE-51.13%+86.5%
XXII Price & Volume
22nd Century Group, Inc. (XXII) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operational Deficits Threaten Long-term Solvency
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity and solvency
Key Thesis Takeaways
- 22nd Century Group faces a critical juncture as its proprietary Very Low Nicotine technology fails to achieve the commercial scale necessary to offset structural production costs.
- Despite regulatory milestones, the company's inability to generate positive gross margins—evidenced by a -79.6% margin in 2025Q4—suggests a fundamental disconnect between its R&D focus and market viability.
- Investors should remain cautious given the recurring net losses and the potential for further asset impairments on the $6.1 million in goodwill currently held on the balance sheet.
Verdict Logic
the company's inability to achieve positive free cash flow in nine of the last ten quarters, combined with a 2026Q1 operating margin of -74.0%, indicates an unsustainable business model.
XXII Growth Metrics
22nd Century Group, Inc. (XXII) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-1.88%
5 Years-24.17%
3 Years-44.17%
TTM-19.79%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM71.01%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM99.45%
Return on Capital
10 Years-63.35%
5 Years-89.24%
3 Years-118.55%
Last Year-72.57%
Peers Comparison
Key metrics vs top competitors for 22nd Century Group, Inc. (XXII)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $4.36 | $1.5M | -0.08 | -40.66% | -71.7% | -51.13% | — | |
| $72.96 | $121.98B | 17.75 | -1.49% | 36.91% | — | — | |
| $187.79 | $292.68B | 25.87 | 7.31% | 26.74% | — | — | |
| $61.80 | $133.88B | 13.23 | -0.99% | 21.04% | 21.69% | — | |
| $2.75 | $1.03B | -112.24 | 64.4% | -0.98% | -0.18% | — | |
| $0.95 | $365.74M | -1.53 | 5.8% | -91.63% | -38.64% | — |
Compare XXII vs Peers
22nd Century Group, Inc. (XXII) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
XXII SEC Filings & Documents
22nd Century Group, Inc. (XXII) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when XXII posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
XXII Frequently Asked Questions
22nd Century Group, Inc. (XXII) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is 22nd Century Group, Inc.'s revenue?
22nd Century Group, Inc. (XXII) reported $8.9M in revenue for fiscal year 2025.
How fast is 22nd Century Group, Inc. growing?
22nd Century Group, Inc. (XXII) saw revenue decline by 40.7% over the past year.
Is XXII profitable?
22nd Century Group, Inc. (XXII) reported a net loss of $4.0M for fiscal year 2025.
Dividend & Returns
What is XXII's return on equity?
22nd Century Group, Inc. (XXII) has a return on equity (ROE) of -51.1%. Negative ROE indicates the company is unprofitable.
What is 22nd Century Group, Inc.'s free cash flow?
22nd Century Group, Inc. (XXII) had negative free cash flow of $7.9M in fiscal year 2025, likely due to heavy capital investments.